NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹72 Cr | ₹-68 Cr | ₹9.00 Cr | ₹76 Cr | ₹9.80 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NATCO PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹-68 Cr |
| Mar2023 | ₹9.00 Cr |
| Mar2022 | ₹76 Cr |
| Mar2021 | ₹9.80 Cr |
How is Net Cash Inflow / Outflow of NATCO PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹72 Cr | Positive | |
| Mar2024 | ₹-68 Cr | Negative | |
| Mar2023 | ₹9.00 Cr | -88.16 | |
| Mar2022 | ₹76 Cr | 675.51 | |
| Mar2021 | ₹9.80 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹14,861.7 Cr | 0.7% | -7.1% | -26.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,439.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,903.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,466.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,653.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,924.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 0.7% |
-7.1% |
-26.5% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses